Kaken Pharmaceutical Co., Ltd. (4521)

Overview

Kaken Pharmaceutical Co., Ltd., founded in 1917 and headquartered in Tokyo, Japan, operates globally in the pharmaceutical, medical devices, and agrochemical sectors. The company is dedicated to the research, development, production, marketing, and sale of a diverse range of medical and health-related products. Its portfolio spans from pharmaceuticals and medical devices addressing various medical conditions to agrochemicals and animal health products essential for food safety and security. Kaken Pharmaceutical is actively engaged in advancing new therapies, with several products in clinical trials aiming at treating a variety of medical conditions, showcasing its commitment to improving patient care and agricultural efficiency.

Products and Services

Kaken Pharmaceutical Co., Ltd. offers a broad array of products and services, including:

• Clenafin: A topical solution for treating onychomycosis, offering patients a targeted approach to nail fungus elimination.
• Artz: An anti-osteoarthritis agent that provides relief from the symptoms associated with osteoarthritis, improving quality of life for sufferers.
• Fiblast: A pioneering wound-healing agent designed to accelerate the healing process of wounds, enhancing patient recovery.
• Ecclock: A treatment aimed at individuals suffering from primary axillary hyperhidrosis, reducing excessive underarm sweating.
• Regroth: A periodontal regenerative agent that promotes the regeneration of periodontal tissues, aiding in the treatment of periodontal diseases.
• Hernicore: Developed for the treatment of lumbar disc herniation, offering an alternative to more invasive treatments.
• Seprafilm: An adhesion barrier used mainly in surgical and gynecological procedures to minimize post-operative adhesion complications.
• Polyoxins: Fungicides used in agriculture to protect crops from fungal diseases, ensuring food security.
• Pentoxazone and Metamifop: Herbicides specifically designed for rice cultivation, aiding in the efficient management of weed growth.
• Salinomycin: An anti-coccidial feed additive for chickens, aimed at preventing the spread of coccidiosis in poultry farming.

In addition to these products, Kaken Pharmaceutical is immersed in the development of innovative treatments for various medical conditions through extensive clinical trials. These trials include therapies for head lice, vascular malformations, hyperhidrosis, solid tumors, atopic dermatitis, peripheral neuropathic pain, primary biliary cholangitis, and congenital adrenal hyperplasia, reflecting the company’s dedication to expanding its contribution to global health care.